N-Glycomic Signature of Stage II Colorectal Cancer and Its Association With the Tumor Microenvironment-Reference-Cited by-同舟云学术

N-Glycomic Signature of Stage II Colorectal Cancer and Its Association With the Tumor Microenvironment

Published:2021 Issue: Volume:20 Page:100057
ISSN:1535-9476
Container-title:Molecular & Cellular Proteomics
language:en
Short-container-title:Molecular & Cellular Proteomics

Author:

Boyaval Fanny^ORCID,van Zeijl René,Dalebout Hans,Holst Stephanie^ORCID,van Pelt Gabi,Fariña-Sarasqueta Arantza^ORCID,Mesker Wilma^ORCID,Tollenaar Rob,Morreau Hans,Wuhrer Manfred^ORCID,Heijs Bram^ORCID

Funder

Leids Universitair Medisch Centrum

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Analytical Chemistry

Reference59 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Global cancer transitions according to the human development index (2008–2030): A population-based study;Bray;Lancet Oncol.,2012

3. Comparison of the eighth version of the American Joint Committee on Cancer manual to the seventh version for colorectal cancer: A retrospective review of our data;Tong;World J. Clin. Oncol.,2018

4. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer;Sandberg;BMC Cancer,2019

5. The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: Validation in the VICTOR trial;Huijbers;Ann. Oncol.,2013

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of serum glycan signatures in three major gastrointestinal cancers by high-throughput N-glycome profiling;2024-09-09

2. Tumor- and immune-derivedN-acetyl-β-D-hexosaminidase drive colorectal cancer and stratify patient risk;2024-07-04

3. Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for 2021–2022;Mass Spectrometry Reviews;2024-06-24

4. State of the Art in CAR-T Cell Therapy for Solid Tumors: Is There a Sweeter Future?;Cells;2024-04-23

5. Mass spectrometry imaging methods for visualizing tumor heterogeneity;Current Opinion in Biotechnology;2024-04